Early implantation of cardiac resynchronization therapy can prevent irreversible remodeling in heart failure patients with electrical dyssynchrony.
CRT efficacy depends on both the quality and quantity of electrical dyssynchrony, requiring individualized patient selection and optimal left ventricular lead positioning.
Absolute Event Rate: 0% vs 0%
ABSTRACT Cardiac resynchronization therapy (CRT) essentially targets electrical dyssynchrony, one of the key drivers in heart failure (HF). Its efficacy depends on both the quality (QRS morphology) and quantity (QRS duration) of dyssynchrony, requiring individualized patient selection. While drug therapy for HF has a limited effect on this substrate, early implantation of CRT can prevent irreversible remodeling and facilitate optimization of medical therapy. CRT should be recognized as an essential component within a comprehensive strategy for HF management in patients with appropriate indications.
Ogano et al. (Fri,) reported a other. Early implantation of cardiac resynchronization therapy can prevent irreversible remodeling in heart failure patients with electrical dyssynchrony.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: